A simple total synthesis of the quinoline alkaloid, orixiarine was achieved from N-methylaniline and 1-bromo-3-methyl-2-butanone.
Introduction
In the recent past, a hemiterpenoid quinoline alkaloid, named orixiarine (Graph 1) was isolated from Skimmia laureola (Rutaceae), which is an aromatic gregarious evergreen shrub found in Western Himalayas and Kashmir [1, 2] . The plant is used for the treatment of smallpox [3] and as an insecticide for domestic animals [4, 5] .
Earlier, our program of synthesis of quinoline alkaloids, in particular the hemiterpenoid quinoline alkaloid [6] was achieved with a multi-step protocol and in comparatively less yield. However, we aimed of providing a high yield procedure with significantly less steps, which also pave a path for deriving various alkaloids like edulinine, N-methylflindersine etc. [7] . Herein we report our investigations which have resulted in a four-step, convenient total synthesis of orixiarine starting from N-methylaniline (2). When 4-hydroxy-N-methyl-2-quinolinone (3) [8, 9] was stirred with 1-bromo-3-methyl-2-butanone (4) [10] in 4% sodium hydroxide solution gave 5 (85%) along with a minor product 6 (7%) under nucleophilic conditions and subsequent elimination of hydrogenbromide. Compound 5 on treatment with p-methyltoluenesulphonate and potassium carbonate yielded the final product 1 which on analysis by 1 H-NMR, 13 C-NMR and mass spectra, is found to be identical with that isolated from Skimmia laureola [1] (Scheme 1).
Experimental
Thin layer chromatography was used to access the reactions and the purity of products. Melting Points were determined on a Boetius Microheating Table and Mettler-FP5 Melting apparatus and are uncorrected. IR spectra were recorded in Shimadzu-8201FT instrument in KBr disc and only noteworthy absorption levels (reciprocal centimeter) are listed.
1 H-NMR spectra were recorded in a AMX-400 MHz spectrometer in CDCl 3 solution; chemical shifts are expressed in ppm (δ) relative TMS, coupling constants (J) in Hz.
13 C-NMR was also recorded on the same AMX-400 MHz spectrometer with Tetra methyl silane (TMS) as internal standard. Mass spectra were recorded on a Jeol-D-300 mass spectrometer. CHN analyses were carried out on a Carlo Erba 106 and Perkin-Elmer Model 240 analysers.
Typical Procedures Preparation of 4-hydroxy-1-methylquinolin-2-one (3):
4-Hydroxy-1-methylquinolin-2-one (3) was prepared by reported procedure [8, 9] .
Preparation of 1-bromo-3-methyl-2-butanone (4): A solution of 3-methyl-2-butanone (8.6 g, 10.5 mL, 0.01 mol) and 60 mL of anhydrous methanol was stirred and cooled in an ice-salt bath from 0˚C -5˚C and 5.46 mL (0.01 mol) of bromine was added in a rapid steady stream from the dropping funnel. During this time, the temperature was allowed to rise but was not permitted to exceed 10˚C. The reaction temperature was then maintained at 10˚C throughout the remaining reaction time. The red colour of the solution faded gradually in about 45 min, 30 mL of water was then added and the mixture was stirred at room temperature overnight. To this solution, 90 mL of water was added and the mixture was washed with four little portion of ether. The ether layers were combined and washed with 20 mL of aq 10% potassium carbonate and then twice with 20 mL portions of water. The ether layer was dried for 15 min over a few gram of sodium sulfate and the ether was evaporated to get 1-bromo-3-methyl-2-butanone. (yield: 10.0 g, 6.8 mL, bp 83˚C -85˚C) [10] .
Preparation of 4-hydroxy-1-methyl-3-(3'-methyl-2'-oxobutyl)-quinolin-2-one (5):
4-Hydroxy-1-methylquinolin-2-one (3) (0.700 g, 0.004 mol) and 1-bromo-3-methyl-2 butanone (4) (0.66 mL, 0.004 mol) was stirred in 4% sodium hydroxide solution at 70˚C -80˚C for 7 -8 hr. The solid separated from the reaction mixture was filtered, dried and separated by column chromatography using pet. ether-ethyl acetate (95:5) which gave two products. Specific details on each product (5 and 6) are as follows.
Data for 5: mp 234˚C; yield 85%; IR (KBr, γmax) 1618, 1680, 3350 cm 
Conclusion
In conclusion, a simple synthesis of the hemiterpenoid quinoline alkaloid, orixiarine was achieved and characterized. This paves the path for further exploration of the compound towards various potential biological studies.
